Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril

Journal of Molecular and Cellular Cardiology
Olga PechánováFedor Simko

Abstract

Long-term administration of NG-nitro-L-arginine methyl ester (L-NAME) induces development of NO-deficient hypertension. The aim of the present study was to determine whether treatment with the angiotensin-converting enzyme (ACE) inhibitor captopril can prevent hypertension, left ventricular (LV) hypertrophy, changes in nucleic acid concentration, protein synthesis and protein profile of the left ventricle. Four groups of rats were investigated: control, L-NAME 40 mg/kg/day, captopril 100 mg/kg/day, L-NAME 40 mg/kg/day along with captopril 100 mg/kg/day. NO-synthase activity in the left ventricle was found to be decreased by 69% in the L-NAME group. Captopril did not influence this inhibition of NO-synthase activity. However, it completely prevented hypertension and left ventricular hypertrophy development. The increase in left ventricular RNA and DNA concentration and -14C-leucine incorporation observed in the L-NAME group was completely prevented by simultaneous captopril treatment. The protein profile of the left ventricle in the L-NAME group was characterized by higher concentration of metabolic proteins (MP), soluble collagenous proteins (SCP) and of hydroxyproline in insoluble collagenous proteins (ICP). The concentration ...Continue Reading

Citations

Sep 30, 2006·Molecular and Cellular Biochemistry·Silvie HojnáJaroslav Kunes
Aug 15, 2002·European Journal of Pharmacology·Vito De Gennaro ColonnaEugenio Muller
Sep 21, 2001·Journal of Hypertension·M A Rossi, M Colombini-Netto
Apr 27, 2004·Journal of Hypertension·Olga PechánováJosef Zicha
Jul 17, 2004·Journal of Hypertension·Olga PechánováRamaroson Andriantsitohaina
Aug 6, 2009·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Fedor SimkoLudovit Paulis
Aug 6, 2009·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Ludovit PaulisFedor Simko
Aug 6, 2009·Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension·Stanislava VrankováOlga Pechanova
Sep 18, 2010·Journal of Hypertension·Olga Pechanova, Fedor Simko
Sep 18, 2010·Journal of Hypertension·Stanislava VrankovaOlga Pechanova
Oct 13, 2005·Kidney & Blood Pressure Research·Mahmoud M KhattabOthman Al-Shabanah
May 14, 2010·Journal of Inflammation·José L Miguel-CarrascoCarmen M Vázquez
Sep 15, 2005·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Hana RauchováJosef Zicha
Mar 24, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Josef ZichaJaroslav Kunes
Jul 18, 2008·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Ludovit PaulisFedor Simko
Mar 21, 2000·Journal of Molecular and Cellular Cardiology·I BernátováF Simko
Feb 27, 2007·European Journal of Pharmacology·Olga PechánováJaroslav Kunes
Jun 14, 2005·European Journal of Clinical Investigation·F SimkoI Bernatova
Aug 19, 2007·European Journal of Clinical Investigation·F Simko
Oct 10, 2014·British Journal of Pharmacology·O PechánováP Ferdinandy
Aug 4, 2015·Clinical and Experimental Pharmacology & Physiology·Sarawoot BunbuphaPoungrat Pakdeechote
May 6, 2016·Oxidative Medicine and Cellular Longevity·Stanislava VrankováJosef Zicha
Feb 1, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fedor SimkoLudovit Paulis
Jan 16, 2018·Oxidative Medicine and Cellular Longevity·Martina CebovaOlga Pechanova
Mar 1, 2001·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Lindsay BrownDarryl Burstow
Oct 5, 2018·International Journal of Molecular Sciences·Fedor SimkoLudovit Paulis
Jan 1, 2010·Journal of Pineal Research·Ludovit PaulisFedor Simko
Jul 26, 2005·American Journal of Physiology. Heart and Circulatory Physiology·David BellBarbara J McDermott
Feb 23, 2019·Clinical and Experimental Pharmacology & Physiology·Tomas Baka, Fedor Simko
Mar 11, 2008·Molecular and Cellular Biochemistry·Anna SpánikováMiroslav Barancík
May 6, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Michaela KosutovaMartina Cebova
Oct 22, 2005·Clinical Science·Olga PechánováJaroslav Kunes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.